The inhaler is packaged within a moisture-protective foil tray with a desiccant and a peelable lid in the following packs: Trelegy Ellipta 100/62.5/25 mcg 30 inhalations (60 blisters) and Trelegy ...
The FDA has approved an expanded label for GlaxoSmithKline’s new Trelegy Ellipta inhaler, allowing it to be used in a broader population of patients with chronic obstructive pulmonary disease ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback